These results show that MCL-1 is critical for c-MYC-driven pre-B/B-lymphoma development, and suggest that alterations in other core components of the apoptotic machinery can compensate for a reduction in MCL-1 levels. The gene discussed is MCL1; the disease is lymphoma.